Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014

Bill: 113-hr-594
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
Introduced: 2013-02-08 in the House
Policy area: Health
Subjects: Cardiovascular and respiratory health
Child health
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health information and medical records
Health programs administration and funding
Medical education
Medical research
Minority health
Musculoskeletal and skin diseases
Research administration and funding

Summary:
action_date: 2013-02-08
text: 
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 - Amends the Public Health Service Act to revise the muscular dystrophy research program of the National Institutes of Health (NIH).
 
Expands the range of forms of muscular dystrophy included within the program. Requires the research conducted through Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers to include cardiac and pulmonary function research. Requires the Director of NIH to ensure the sharing of data between such centers.
 
Revises the composition of the Muscular Dystrophy Coordinating Committee (MDCC) to include the Social Security Administration and the United States Administration for Community Living.
 
Requires the MDCC to meet at least two times per year. Requires the MDCC Action Plan to provide for: (1) health economic studies to demonstrate the cost-effectiveness of providing independent living resources and support to patients with various forms of muscular dystrophy, (2) studies to determine optimal clinical care interventions for adults with various forms of muscular dystrophy, and (3) the development of clinical interventions to improve the health of adults with various forms of muscular dystrophy.
 
Requires the MDCC to develop a plan to expedite the evaluation and approval of emerging therapies and personalized medicines that have the potential to decrease fatal disease progression across the various forms of muscular dystrophy.
 
Requires the Secretary of Health and Human Services (HHS), in carrying out epidemiological activities regarding Duchenne and other forms of muscular dystrophies, to ensure that data from different racial and ethnic populations is captured and made publicly available to investigators conducting public or private research on muscular dystrophy. Directs the Secretary to foster ongoing engagement and collaboration between the surveillance program and the research centers.
 
Amends the Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2001 to authorize the Secretary to: (1) update and disseminate widely existing Duchenne-Becker muscular dystrophy care considerations for pediatric patients, and (2) develop and disseminate widely Duchenne-Becker muscular dystrophy considerations for adult patients and acute care considerations for all muscular dystrophy populations. Directs that such care considerations should build upon existing efforts currently underway for specified forms of muscular dystrophy and incorporate strategies specifically responding to the findings of the national transitions survey of minority, young adult, and adult communities of muscular dystrophy patients.

action_date: 2014-07-24
text: 
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014 - (Sec. 2) Amends the Public Health Service Act to revise the muscular dystrophy research program of the National Institutes of Health (NIH).
 
Expands the range of forms of muscular dystrophy included within the program. Requires the research conducted through Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers to include cardiac and pulmonary function research. Requires the Director of NIH to ensure the sharing of data between such centers.
 
Revises the composition of the Muscular Dystrophy Coordinating Committee (MDCC) to include the Social Security Administration and the United States Administration for Community Living.
 
Requires the MDCC to meet at least two times per year. Requires the MDCC Action Plan to provide for: (1) health economic studies to demonstrate the cost-effectiveness of providing independent living resources and support to patients with various forms of muscular dystrophy, (2) studies to determine optimal clinical care interventions for adults with various forms of muscular dystrophy, and (3) the development of clinical interventions to improve the health of adults with various forms of muscular dystrophy.
 
(Sec. 3) Requires the Secretary of Health and Human Services (HHS), in carrying out epidemiological activities regarding Duchenne and other forms of muscular dystrophy, to ensure that data are representative of all affected populations and shared in a timely manner.
 (Sec. 4) Amends the Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2001 to authorize the Secretary to cooperate with professional organizations and the patient community in the development and issuance of care considerations, including acute care considerations, for pediatric and adult muscular dystrophy patients. Authorizes the Secretary, in developing and updating care considerations, to incorporate strategies specifically responding to the findings of the national transitions survey of minority, young adult, and adult communities of muscular dystrophy patients.
action_date: 2014-07-28
text: 

(This measure has not been amended since it was reported to the House on July 24, 2014. The summary of that version is repeated here.)

 
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014 - (Sec. 2) Amends the Public Health Service Act to revise the muscular dystrophy research program of the National Institutes of Health (NIH).
 
Expands the range of forms of muscular dystrophy included within the program. Requires the research conducted through Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers to include cardiac and pulmonary function research. Requires the Director of NIH to ensure the sharing of data between such centers.
 
Revises the composition of the Muscular Dystrophy Coordinating Committee (MDCC) to include the Social Security Administration and the United States Administration for Community Living.
 
Requires the MDCC to meet at least two times per year. Requires the MDCC Action Plan to provide for: (1) health economic studies to demonstrate the cost-effectiveness of providing independent living resources and support to patients with various forms of muscular dystrophy, (2) studies to determine optimal clinical care interventions for adults with various forms of muscular dystrophy, and (3) the development of clinical interventions to improve the health of adults with various forms of muscular dystrophy.
 
(Sec. 3) Requires the Secretary of Health and Human Services (HHS), in carrying out epidemiological activities regarding Duchenne and other forms of muscular dystrophy, to ensure that data are representative of all affected populations and shared in a timely manner.
 (Sec. 4) Amends the Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2001 to authorize the Secretary to cooperate with professional organizations and the patient community in the development and issuance of care considerations, including acute care considerations, for pediatric and adult muscular dystrophy patients. Authorizes the Secretary, in developing and updating care considerations, to incorporate strategies specifically responding to the findings of the national transitions survey of minority, young adult, and adult communities of muscular dystrophy patients.
action_date: 2014-09-18
text: 

(This measure has not been amended since it was reported to the House on July 24, 2014. The summary of that version is repeated here.)

 
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014 - (Sec. 2) Amends the Public Health Service Act to revise the muscular dystrophy research program of the National Institutes of Health (NIH).
 
Expands the range of forms of muscular dystrophy included within the program. Requires the research conducted through Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers to include cardiac and pulmonary function research. Requires the Director of NIH to ensure the sharing of data between such centers.
 
Revises the composition of the Muscular Dystrophy Coordinating Committee (MDCC) to include the Social Security Administration and the United States Administration for Community Living.
 
Requires the MDCC to meet at least two times per year. Requires the MDCC Action Plan to provide for: (1) health economic studies to demonstrate the cost-effectiveness of providing independent living resources and support to patients with various forms of muscular dystrophy, (2) studies to determine optimal clinical care interventions for adults with various forms of muscular dystrophy, and (3) the development of clinical interventions to improve the health of adults with various forms of muscular dystrophy.
 
(Sec. 3) Requires the Secretary of Health and Human Services (HHS), in carrying out epidemiological activities regarding Duchenne and other forms of muscular dystrophy, to ensure that data are representative of all affected populations and shared in a timely manner.
 (Sec. 4) Amends the Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2001 to authorize the Secretary to cooperate with professional organizations and the patient community in the development and issuance of care considerations, including acute care considerations, for pediatric and adult muscular dystrophy patients. Authorizes the Secretary, in developing and updating care considerations, to incorporate strategies specifically responding to the findings of the national transitions survey of minority, young adult, and adult communities of muscular dystrophy patients.
action_date: 2014-09-26
text: 

(This measure has not been amended since it was reported to the House on July 24, 2014. The summary of that version is repeated here.)

 
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014 - (Sec. 2) Amends the Public Health Service Act to revise the muscular dystrophy research program of the National Institutes of Health (NIH).
 
Expands the range of forms of muscular dystrophy included within the program. Requires the research conducted through Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers to include cardiac and pulmonary function research. Requires the Director of NIH to ensure the sharing of data between such centers.
 
Revises the composition of the Muscular Dystrophy Coordinating Committee (MDCC) to include the Social Security Administration and the United States Administration for Community Living.
 
Requires the MDCC to meet at least two times per year. Requires the MDCC Action Plan to provide for: (1) health economic studies to demonstrate the cost-effectiveness of providing independent living resources and support to patients with various forms of muscular dystrophy, (2) studies to determine optimal clinical care interventions for adults with various forms of muscular dystrophy, and (3) the development of clinical interventions to improve the health of adults with various forms of muscular dystrophy.
 
(Sec. 3) Requires the Secretary of Health and Human Services (HHS), in carrying out epidemiological activities regarding Duchenne and other forms of muscular dystrophy, to ensure that data are representative of all affected populations and shared in a timely manner.
 (Sec. 4) Amends the Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2001 to authorize the Secretary to cooperate with professional organizations and the patient community in the development and issuance of care considerations, including acute care considerations, for pediatric and adult muscular dystrophy patients. Authorizes the Secretary, in developing and updating care considerations, to incorporate strategies specifically responding to the findings of the national transitions survey of minority, young adult, and adult communities of muscular dystrophy patients.

Legislative actions:
action_date: 2014-09-26
text: Became Public Law No: 113-166.
action_date: 2014-09-26
text: Became Public Law No: 113-166.
action_date: 2014-09-26
text: Signed by President.
action_date: 2014-09-26
text: Signed by President.
action_date: 2014-09-23
text: Presented to President.
action_date: 2014-09-23
text: Presented to President.
action_date: 2014-09-19
text: Message on Senate action sent to the House.
action_date: 2014-09-18
text: Passed Senate without amendment by Unanimous Consent. (consideration: CR S5862)
action_date: 2014-09-18
text: Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5862)
action_date: 2014-08-01
text: Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 529.
action_date: 2014-07-29
text: Received in the Senate.
action_date: 2014-07-28
text: The Speaker announced the title of H.R. 594 was amended in the form at the desk. Agreed to without objection.
action_date: 2014-07-28
text: The title of the measure was amended. Agreed to without objection.
action_date: 2014-07-28
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2014-07-28
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6933)
action_date: 2014-07-28
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6933)
action_date: 2014-07-28
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 594.
action_date: 2014-07-28
text: Considered under suspension of the rules. (consideration: CR H6933-6935)
action_date: 2014-07-28
text: Mr. Burgess moved to suspend the rules and pass the bill, as amended.
action_date: 2014-07-24
text: Placed on the Union Calendar, Calendar No. 416.
action_date: 2014-07-24
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-556.
action_date: 2014-07-24
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-556.
action_date: 2014-07-15
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2014-07-15
text: Committee Consideration and Mark-up Session Held.
action_date: 2014-07-14
text: Committee Consideration and Mark-up Session Held.
action_date: 2014-06-19
text: Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent .
action_date: 2014-06-19
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2013-02-08
text: Referred to the Subcommittee on Health.
action_date: 2013-02-08
text: Referred to the House Committee on Energy and Commerce.
action_date: 2013-02-08
text: Introduced in House
action_date: 2013-02-08
text: Introduced in House

Enacted as: number: 113-166